| Literature DB >> 20497544 |
Yue Him Wong1, Shawn M Arellano, Huoming Zhang, Timothy Ravasi, Pei-Yuan Qian.
Abstract
BACKGROUND: Metamorphosis in the bryozoan Bugula neritina (Linne) includes an initial phase of rapid morphological rearrangement followed by a gradual phase of morphogenesis. We hypothesized that the first phase may be independent of de novo synthesis of proteins and, instead, involves post-translational modifications of existing proteins, providing a simple mechanism to quickly initiate metamorphosis. To test our hypothesis, we challenged B. neritina larvae with transcription and translation inhibitors. Furthermore, we employed 2D gel electrophoresis to characterize changes in the phosphoproteome and proteome during early metamorphosis. Differentially expressed proteins were identified by liquid chromatography tandem mass spectrometry and their gene expression patterns were profiled using semi-quantitative real time PCR.Entities:
Year: 2010 PMID: 20497544 PMCID: PMC2890537 DOI: 10.1186/1477-5956-8-25
Source DB: PubMed Journal: Proteome Sci ISSN: 1477-5956 Impact factor: 2.480
Figure 1Developmental stages of . (A) Swimming larvae immediately after release from adult, (B) 2 h preancestrulae, sampled 1 h after larval attachment, and (C) 4 h preancestrulae, sampled 3 h after larval attachment. Scale bars = 100 μm.
Figure 2Percent of . At 1 h, individuals that had initiated metamorphosis were counted. At 40 h, only those individuals that had completed metamorphosis (i.e., developed to ancestrulae) were counted. AFSW and DMSO served as controls. Error bars are + 1 S.D., n = 4.
Figure 3Elongation of metamorphosing . Error bars are + 1 S.D, n = 5.
Figure 4Representative 2DE gels stained with (A) phosphoprotein-specific dye, Pro-Q Diamond, and (B) total protein dye, Sypro-Ruby, in swimming larvae, 2 h preancestrulae, and 4 h preancestrulae. Total protein samples (300 μg) were separated on linear IPG strips (pI 4-7) followed by 12% SDS-PAGE. The results presented here are representative of 2 repeats of 3 replicates for each sample. Arrows indicate areas I and II magnified in Figure 6.
Figure 5Detailed analysis of the phosphoproteome of successive stages. (A) Percentage of protein spots that were phosphorylated and (B) the overall intensity of the phosphoproteome, which is the summation of the relative intensity of all the phosphoprotein spots at one stage.
Figure 6A close view of selected phosphoproteins (indicated by arrows) altered during early metamorphosis. (A) Two different areas (I & II) of the phosphoproteome were selected for each developmental stage. (B) The corresponding total protein 2DE gel for Area I and Area II. The 2DE gels presented here are representatives of 2 repeats of 3 replicates for each metamorphic stage.
Figure 7(A) Intensities of selected protein spots and (B) their phosphoprotein:protein spot intensity ratios. Analyzed spots were significantly different (p < 0.01) and showed more than 2 fold variation between the three developmental stages. Spots are shown in Figure 6.
Protein identification by LC-MS/MS of spot no. 4-18 indicated in Figure 6.
| Spot no. | Protein identified | Accession. No. | Mascot score (no. of unique peptide) | MW (kDa)/p | Unique peptide | Miss cleavage | Score | Expect |
|---|---|---|---|---|---|---|---|---|
| 4 | the putative mitochondrial processing peptidase, beta subunit | SRA010777.2, Contig1413_30 | 237(3) | 50.7/5.15 | RIPLAELDAR | 1 | 56 | 2.7e-006 |
| AMGGGANLPSILASK | 0 | 101 | 1.6e-010 | |||||
| LCNNVTNFEVQR | 0 | 86 | 4.7e-009 | |||||
| 5 | the putative mitochondrial processing peptidase, beta subunit | SRA010777.2, Contig1413_30 | 311(5) | 49.8/5.17 | IPLAELDAR | 0 | 52 | 0.0005 |
| RIPLAELDAR | 1 | 62 | 3.4e-005 | |||||
| AMGGGANLPSILASK | 0 | 68 | 3.1e-005 | |||||
| LCNNVTNFEVQR | 0 | 64 | 0.0001 | |||||
| AVGPVEQLDDYGILR | 0 | 61 | 0.00016 | |||||
| 6 | the putative mitochondrial processing peptidase, beta subunit | SRA010777.2, Contig1413_30 | 349(3) | 49.1/5.19 | RIPLAELDAR | 1 | 60 | 9.8e-007 |
| AMGGGANLPSILASK | 0 | 78 | 3.3e-008 | |||||
| LCNNVTNFEVQR | 0 | 86 | 4e-009 | |||||
| 7 | the putative mitochondrial processing peptidase, beta subunit | SRA010777.2, Contig1413_30 | 546(4) | 48.4/5.21 | IPLAELDAR | 0 | 68 | 2.1e-007 |
| RIPLAELDAR | 1 | 56 | 2.8e-006 | |||||
| AMGGGANLPSILASK | 0 | 106 | 5e-011 | |||||
| LCNNVTNFEVQR | 0 | 80 | 1.3e-008 | |||||
| 8 | the putative mitochondrial processing peptidase, beta subunit | SRA010777.2, Contig1413_30 | 976(5) | 47.7/5.23 | IPLAELDAR | 0 | 61 | 1.1e-006 |
| RIPLAELDAR | 1 | 64 | 3.9e-007 | |||||
| AMGGGANLPSILASK | 0 | 93 | 8e-010 | |||||
| LCNNVTNFEVQR | 0 | 82 | 9.2e-009 | |||||
| IESVDAQAVMNVCTK | 0 | 77 | 2.8e-008 | |||||
| 9 | the putative mitochondrial processing peptidase, beta subunit | SRA010777.2, Contig1413_30 | 1154(5) | 47.1/5.25 | IPLAELDAR | 0 | 59 | 1.5e-006 |
| RIPLAELDAR | 1 | 58 | 1.6e-006 | |||||
| AMGGGANLPSILASK | 0 | 90 | 1.5e-009 | |||||
| LCNNVTNFEVQR | 0 | 100 | 1.5e-010 | |||||
| IESVDAQAVMNVCTK | 0 | 84 | 6.3e-009 | |||||
| 10 | the putative mitochondrial processing peptidase, beta subunit | SRA010777.2, Contig1413_30 | 525(4) | 47/5.28 | IPLAELDAR | 0 | 59 | 1.2e-006 |
| RIPLAELDAR | 1 | 62 | 5.7e-007 | |||||
| AMGGGANLPSILASK | 0 | 114 | 7.4e-012 | |||||
| LCNNVTNFEVQR | 0 | 94 | 5.5e-010 | |||||
| 11 | Severin | SRA010777.2, Contig4181_4 | 262(4) | 49.1/5.1 | LVYMDGGVASGFR | 0 | 65 | 3.7e-007 |
| YNAAAYCQQLESER | 0 | 58 | 1.4e-006 | |||||
| TDVLEEDSTPETHEFYEK | 0 | 88 | 1.6e-009 | |||||
| TVELDTYHNDGPVQHR | 0 | 52 | 1.1e-005 | |||||
| 12 | Severin | SRA010777.2, Contig4181_4 | 389(4) | 48.4/5.12 | LVYMDGGVASGFR | 0 | 61 | 1e-006 |
| YNAAAYCQQLESER | 0 | 78 | 1.7e-008 | |||||
| TVELDTYHNDGPVQHR | 0 | 52 | 1.1e-005 | |||||
| TDVLEEDSTPETHEFYEK | 0 | 105 | 3.1e-011 | |||||
| 13 | Severin | SRA010777.2, Contig4181_4 | 445(4) | 47.7/5.14 | LVYMDGGVASGFR | 0 | 61 | 1e-006 |
| YNAAAYCQQLESER | 0 | 78 | 1.7e-008 | |||||
| TVELDTYHNDGPVQHR | 0 | 52 | 1.1e-005 | |||||
| TDVLEEDSTPETHEFYEK | 0 | 105 | 3.1e-011 | |||||
| 14 | Severin | SRA010777.2, Contig4181_4 | 404(4) | 47.1/5.16 | LVYMDGGVASGFR | 0 | 54 | 6.3e-006 |
| YNAAAYCQQLESER | 0 | 85 | 3e-009 | |||||
| TVELDTYHNDGPVQHR | 0 | 121 | 1.3e-012 | |||||
| TDVLEEDSTPETHEFYEK | 0 | 127 | 2e-013 | |||||
| 15 | Severin | SRA010777.2, Contig4181_4 | 340(3) | 46.5/5.19 | LVYMDGGVASGFR | 0 | 68 | 2.1e-007 |
| YNAAAYCQQLESER | 0 | 87 | 2e-009 | |||||
| TDVLEEDSTPETHEFYEK | 0 | 96 | 2.8e-010 | |||||
| 16 | Severin | SRA010777.2, Contig4181_4 | 1013(7) | 45.9/5.21 | EVQAHESSLFK | 0 | 78 | 2e-008 |
| IYQFNGANCSK | 0 | 57 | 2.3e-006 | |||||
| LVYMDGGVASGFR | 0 | 77 | 2.4e-008 | |||||
| MDFELVAEGTFSK | 0 | 77 | 2e-008 | |||||
| YNAAAYCQQLESER | 0 | 99 | 1.4e-010 | |||||
| TVELDTYHNDGPVQHR | 0 | 122 | 9.6e-013 | |||||
| TDVLEEDSTPETHEFYEK | 0 | 124 | 3.7e-013 | |||||
| 17 | Severin | SRA010777.2, Contig4181_4 | 611(5) | 45.5/5.24 | EVQAHESSLFK | 0 | 52 | 9.8e-006 |
| LVYMDGGVASGFR | 0 | 60 | 1.3e-006 | |||||
| YNAAAYCQQLESER | 0 | 81 | 7.3e-009 | |||||
| TVELDTYHNDGPVQHR | 0 | 113 | 8.3e-012 | |||||
| TDVLEEDSTPETHEFYEK | 0 | 122 | 6.8e-013 | |||||
| 18 | Severin | SRA010777.2, Contig4181_4 | 472(5) | 45.3/5.26 | EVQAHESSLFK | 0 | 57 | 0.0006 |
| HSTQDEYGTAAYK | 0 | 94 | 1.3e-007 | |||||
| YNAAAYCQQLESER | 0 | 79 | 5e-006 | |||||
| TDVLEEDSTPETHEFYEK | 0 | 112 | 3.1e-009 | |||||
| AKTDVLEEDSTPETHEFYEK | 1 | 154 | 1.6e-013 |
Figure 8The gene expression profile of (A) Mitochondrial processing peptidase beta subunit and (B) Severin as determined by qRT-PCR. Significant differences (p < 0.05) as indicated by Student's t-test are indicated by *.